A recent post on the National Institute for Health and Care Excellence (NICE) looks at the partnership between it and the Charity Medicines Access Coalition (CMAC) through which the pair worked to “identify where changes to NHS practices, that NICE can influence, could benefit patients and carers.”
According to the post, the partnership identified the following three areas where it could make a difference:
- Increasing patient involvement in the assessment of new medicines;
- Reviewing how NICE judges the value of new medicines; and
- Using evidence from NHS care, as well as clinical trials in NICE’s decision-making.
To read the full post, click here.